SCHEMBL13355967

SCHEMBL13355967

COc1cc(O)cc2c(=O)cc(-c3ccc(O)cc3)oc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.70
▸ CYP1A2 P05177 1/20 0.70
▸ CYP1B1 Q16678 1/20 0.70
▸ ESR2 Q92731 5/20 0.66
▸ ESR1 P03372 4/20 0.66
▸ APP P05067 2/20 0.61
▸ CSNK2A2 P19784 3/20 0.59
▸ CSNK2B P67870 3/20 0.59
▸ CSNK2A1 P68400 3/20 0.59
▸ MEN1 O00255 4/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ KDM4E B2RXH2 3/20 0.58
▸ ALDH1A1 P00352 3/20 0.58
▸ TP53 P04637 3/20 0.58
▸ CYP3A4 P08684 3/20 0.58
▸ CYP2D6 P10635 3/20 0.58
▸ MAPT P10636 3/20 0.58
▸ CYP2C9 P11712 3/20 0.58
▸ CYP2C19 P33261 3/20 0.58
▸ HPGD P15428 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311766 0.85 ALDH1A1 (0.66) CYP1A1CYP1A2CYP1B1ESR2ESR1
SCHEMBL8934506 0.84 TUBB4A (0.79) CYP1A1CYP1A2CYP1B1APPCSNK2A2
SCHEMBL30269738 0.81 CYP1A2 (0.67) CYP1A1CYP1A2CYP1B1APPCSNK2A2
SCHEMBL10305796 0.81 TERT (0.66) CYP1A1CYP1A2CYP1B1ESR2ESR1
SCHEMBL30685309 0.80 CYP1B1 (0.56) CYP1A1CYP1A2CYP1B1ESR2ESR1
SCHEMBL3928011 0.80 ESR1 (1.00) CYP1A1CYP1A2CYP1B1ESR2ESR1
SCHEMBL10305783 0.80 MEN1 (0.66) CYP1A1CYP1A2CYP1B1APPCSNK2A2
SCHEMBL8934614 0.79 KDM4E (0.74) CYP1A1CYP1A2CYP1B1ESR2CSNK2A2
SCHEMBL2874033 0.78 POLH (0.79) CYP1A1CYP1A2CYP1B1ESR2ESR1
SCHEMBL10305800 0.77 AKR1B1 (0.64) CYP1A1CYP1A2CYP1B1ESR2CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1600061-B1 Oral and/or topical compositions COGNIS IP MAN GMBH (DE) 2010-05-12 — — EP disclosed
Send feedback